vs
景顺(IVZ)与OLIN Corp(OLN)财务数据对比。点击上方公司名可切换其他公司
景顺的季度营收约是OLIN Corp的1.0倍($1.7B vs $1.7B),OLIN Corp净利率更高(-8.6% vs -58.9%,领先50.3%),景顺同比增速更快(6.2% vs -0.4%),过去两年景顺的营收复合增速更高(7.1% vs 0.9%)
景顺是总部位于美国佐治亚州亚特兰大的独立投资管理企业,在全球20个国家设有分支机构,旗下运营景顺、Invesco Perpetual、PowerShares等品牌,普通股为标普500指数成分股,于纽约证券交易所挂牌交易。
奥林公司是美国知名制造企业,主营弹药、氯气及氢氧化钠产品。其历史可追溯至1892年成立的两家企业:富兰克林·W·奥林创立的公平火药公司,以及马西森碱业公司。过往奥林旗下化工厂曾发生安全事故,对员工及周边居民健康造成风险。
IVZ vs OLN — 直观对比
营收规模更大
IVZ
是对方的1.0倍
$1.7B
营收增速更快
IVZ
高出6.6%
-0.4%
净利率更高
OLN
高出50.3%
-58.9%
两年增速更快
IVZ
近两年复合增速
0.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $1.7B | $1.7B |
| 净利润 | $-995.9M | $-143.2M |
| 毛利率 | — | 1.9% |
| 营业利润率 | -86.2% | -9.4% |
| 净利率 | -58.9% | -8.6% |
| 营收同比 | 6.2% | -0.4% |
| 净利润同比 | -575.8% | -1517.8% |
| 每股收益(稀释后) | $-2.61 | $-1.25 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
IVZ
OLN
| Q4 25 | $1.7B | $1.7B | ||
| Q3 25 | $1.6B | $1.7B | ||
| Q2 25 | $1.5B | $1.8B | ||
| Q1 25 | $1.5B | $1.6B | ||
| Q4 24 | $1.6B | $1.7B | ||
| Q3 24 | $1.5B | $1.6B | ||
| Q2 24 | $1.5B | $1.6B | ||
| Q1 24 | $1.5B | $1.6B |
净利润
IVZ
OLN
| Q4 25 | $-995.9M | $-143.2M | ||
| Q3 25 | $356.4M | $43.7M | ||
| Q2 25 | $197.4M | $-2.8M | ||
| Q1 25 | $171.1M | $1.2M | ||
| Q4 24 | $209.3M | $10.1M | ||
| Q3 24 | $55.0M | $-25.2M | ||
| Q2 24 | $132.2M | $72.3M | ||
| Q1 24 | $141.5M | $47.8M |
毛利率
IVZ
OLN
| Q4 25 | — | 1.9% | ||
| Q3 25 | — | 10.7% | ||
| Q2 25 | — | 7.9% | ||
| Q1 25 | — | 9.0% | ||
| Q4 24 | — | 9.4% | ||
| Q3 24 | — | 8.5% | ||
| Q2 24 | — | 14.5% | ||
| Q1 24 | — | 12.7% |
营业利润率
IVZ
OLN
| Q4 25 | -86.2% | -9.4% | ||
| Q3 25 | 16.5% | 4.8% | ||
| Q2 25 | 14.1% | 2.0% | ||
| Q1 25 | 18.1% | 2.7% | ||
| Q4 24 | 19.6% | 2.8% | ||
| Q3 24 | 6.6% | 1.0% | ||
| Q2 24 | 13.9% | 8.3% | ||
| Q1 24 | 14.4% | 5.9% |
净利率
IVZ
OLN
| Q4 25 | -58.9% | -8.6% | ||
| Q3 25 | 21.7% | 2.6% | ||
| Q2 25 | 13.0% | -0.2% | ||
| Q1 25 | 11.2% | 0.1% | ||
| Q4 24 | 13.1% | 0.6% | ||
| Q3 24 | 3.6% | -1.6% | ||
| Q2 24 | 8.9% | 4.4% | ||
| Q1 24 | 9.6% | 2.9% |
每股收益(稀释后)
IVZ
OLN
| Q4 25 | $-2.61 | $-1.25 | ||
| Q3 25 | $0.66 | $0.37 | ||
| Q2 25 | $-0.03 | $-0.01 | ||
| Q1 25 | $0.38 | $0.01 | ||
| Q4 24 | $0.46 | $0.10 | ||
| Q3 24 | $0.12 | $-0.21 | ||
| Q2 24 | $0.29 | $0.62 | ||
| Q1 24 | $0.31 | $0.40 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $1.0B | $167.6M |
| 总债务越低越好 | $1.8B | $2.8B |
| 股东权益账面价值 | $12.2B | $1.8B |
| 总资产 | $27.1B | $7.3B |
| 负债/权益比越低杠杆越低 | 0.15× | 1.55× |
8季度趋势,按日历期对齐
现金及短期投资
IVZ
OLN
| Q4 25 | $1.0B | $167.6M | ||
| Q3 25 | $973.1M | — | ||
| Q2 25 | $922.7M | — | ||
| Q1 25 | $821.7M | — | ||
| Q4 24 | $986.5M | $175.6M | ||
| Q3 24 | $1.0B | — | ||
| Q2 24 | $878.5M | — | ||
| Q1 24 | $895.7M | — |
总债务
IVZ
OLN
| Q4 25 | $1.8B | $2.8B | ||
| Q3 25 | $1.6B | $3.0B | ||
| Q2 25 | $1.9B | $3.0B | ||
| Q1 25 | $964.8M | $3.0B | ||
| Q4 24 | $890.6M | $2.7B | ||
| Q3 24 | $890.3M | $2.8B | ||
| Q2 24 | $890.1M | $2.8B | ||
| Q1 24 | $1.3B | $2.7B |
股东权益
IVZ
OLN
| Q4 25 | $12.2B | $1.8B | ||
| Q3 25 | $14.0B | $2.0B | ||
| Q2 25 | $13.9B | $2.0B | ||
| Q1 25 | $14.7B | $2.0B | ||
| Q4 24 | $14.6B | $2.0B | ||
| Q3 24 | $14.8B | $2.1B | ||
| Q2 24 | $14.6B | $2.1B | ||
| Q1 24 | $14.6B | $2.2B |
总资产
IVZ
OLN
| Q4 25 | $27.1B | $7.3B | ||
| Q3 25 | $28.4B | $7.6B | ||
| Q2 25 | $28.5B | $7.7B | ||
| Q1 25 | $28.1B | $7.7B | ||
| Q4 24 | $27.0B | $7.6B | ||
| Q3 24 | $27.5B | $7.5B | ||
| Q2 24 | $27.2B | $7.7B | ||
| Q1 24 | $28.1B | $7.6B |
负债/权益比
IVZ
OLN
| Q4 25 | 0.15× | 1.55× | ||
| Q3 25 | 0.12× | 1.52× | ||
| Q2 25 | 0.14× | 1.52× | ||
| Q1 25 | 0.07× | 1.50× | ||
| Q4 24 | 0.06× | 1.34× | ||
| Q3 24 | 0.06× | 1.34× | ||
| Q2 24 | 0.06× | 1.31× | ||
| Q1 24 | 0.09× | 1.24× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $455.8M | $321.2M |
| 自由现金流经营现金流 - 资本支出 | $432.2M | — |
| 自由现金流率自由现金流/营收 | 25.5% | — |
| 资本支出强度资本支出/营收 | 1.4% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $1.4B | — |
8季度趋势,按日历期对齐
经营现金流
IVZ
OLN
| Q4 25 | $455.8M | $321.2M | ||
| Q3 25 | $606.2M | $26.7M | ||
| Q2 25 | $547.9M | $212.3M | ||
| Q1 25 | $-84.6M | $-86.0M | ||
| Q4 24 | $316.9M | $141.7M | ||
| Q3 24 | $438.4M | $189.9M | ||
| Q2 24 | $489.1M | $90.6M | ||
| Q1 24 | $-54.4M | $81.0M |
自由现金流
IVZ
OLN
| Q4 25 | $432.2M | — | ||
| Q3 25 | $586.4M | $-44.4M | ||
| Q2 25 | $530.4M | — | ||
| Q1 25 | $-108.0M | $-147.4M | ||
| Q4 24 | $309.9M | $90.7M | ||
| Q3 24 | $410.0M | $146.6M | ||
| Q2 24 | $462.4M | $34.1M | ||
| Q1 24 | $-75.4M | $36.7M |
自由现金流率
IVZ
OLN
| Q4 25 | 25.5% | — | ||
| Q3 25 | 35.7% | -2.6% | ||
| Q2 25 | 35.0% | — | ||
| Q1 25 | -7.1% | -9.0% | ||
| Q4 24 | 19.5% | 5.4% | ||
| Q3 24 | 27.1% | 9.2% | ||
| Q2 24 | 31.2% | 2.1% | ||
| Q1 24 | -5.1% | 2.2% |
资本支出强度
IVZ
OLN
| Q4 25 | 1.4% | — | ||
| Q3 25 | 1.2% | 4.2% | ||
| Q2 25 | 1.2% | — | ||
| Q1 25 | 1.5% | 3.7% | ||
| Q4 24 | 0.4% | 3.1% | ||
| Q3 24 | 1.9% | 2.7% | ||
| Q2 24 | 1.8% | 3.4% | ||
| Q1 24 | 1.4% | 2.7% |
现金转化率
IVZ
OLN
| Q4 25 | — | — | ||
| Q3 25 | 1.70× | 0.61× | ||
| Q2 25 | 2.78× | — | ||
| Q1 25 | -0.49× | -71.67× | ||
| Q4 24 | 1.51× | 14.03× | ||
| Q3 24 | 7.97× | — | ||
| Q2 24 | 3.70× | 1.25× | ||
| Q1 24 | -0.38× | 1.69× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IVZ
| Investment Advice | $1.2B | 73% |
| Distribution And Shareholder Service | $382.7M | 23% |
| Financial Service Other | $51.0M | 3% |
| Investment Performance | $28.9M | 2% |
OLN
| Chlorinechlorinederivativesandothercoproducts | $456.2M | 27% |
| Causticsoda | $400.2M | 24% |
| Militaryandlawenforcement | $304.6M | 18% |
| Epoxyresins | $194.9M | 12% |
| Aromaticsandallylics | $164.4M | 10% |
| Commercial | $144.8M | 9% |